Company Filing History:
9 out of 721 
2 out of 378 
Years Active: 2012-2019
Title: Carsten Möller: Innovator in Hormonal Therapeutics
Introduction
Carsten Möller is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of hormonal therapeutics, particularly through his innovative patents. With a total of 11 patents to his name, Möller has focused on developing treatments for sexual hormone-dependent diseases.
Latest Patents
Möller's latest patents include groundbreaking work on Selective Progesterone Receptor Modulators (SPRM). This invention addresses the treatment and prophylaxis of sexual hormone-dependent diseases, particularly endometriosis and uterine fibroids. The patent emphasizes maintaining circulating endogenous estradiol concentrations in treated women within a specific range. Another notable patent involves 17-hydroxy-17-pentafluoroethylestra-4,9(10)-diene 11-aryl derivatives, which have progesterone-antagonizing action. This invention is aimed at treating various disorders, including fibroids, endometriosis, and hormone-dependent cancers.
Career Highlights
Throughout his career, Carsten Möller has worked with notable companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His work has significantly impacted the pharmaceutical industry, particularly in the development of hormonal therapies.
Collaborations
Möller has collaborated with esteemed colleagues, including Wolfgang Schwede and Ulrich Klar. These partnerships have further enhanced his research and development efforts in the field of hormonal therapeutics.
Conclusion
Carsten Möller stands out as an influential inventor in the realm of hormonal treatments. His innovative patents and collaborations have paved the way for advancements in addressing sexual hormone-dependent diseases.